The involvement of central nervous system histamine receptors in psychological stress-induced exacerbation of allergic airway inflammation in mice Asthma is characterized by chronic airway inflammation in response to various types of inherited and environmental factors, which leads to wheezing, coughing, tightness in the chest, and shortness of breath. Increasing evidence has indicated that asthma is not a disease but a syndrome with heterogeneous pathobiology, clinical course, and therapeutic response to medicines. Therefore, asthma phenotypes based on pathological and clinical features such as types of airway inflammation and risk factors for exacerbations have been proposed to identify more effective asthma therapies specific for each phenotype. 1 In asthma pathophysiology, type 2 T-helper (Th2) cytokines, such as interleukin (IL)-4, IL-5, and IL-13, play pivotal roles in regulating the behavior of inflammatory cells; inducing B cell isotype switching to produce IgE; and promoting the accumulation, activation, and prolonged survival of eosinophils. These events initiate and maintain the cardinal features of asthma, such as asthmatic airway inflammation, thereby accelerating airway responsiveness and epithelial mucus secretion. 2 Psychological and psychosocial stressors have been long recognized as important universal risk factors for asthma exacerbations, 3e9 which are accompanied by aggravation of airway inflammation attributable to further skewing towards a Th2-dominant cytokine profile. 10e14 The cognitive processes accompanying psychological stress are deeply connected to asthma exacerbations. Activation of the anterior cingulate cortex and insula by psychological stimuli exhibited a greater decrease in forced expiratory volume in 1 s (FEV 1 ), increased recruitment of eosinophils, and diminished glucocorticoid inhibition of TNF-a production. 15 The intensity of activation in the anterior insula in response to asthma-relevant psychological stimuli is correlated with the severity of airway inflammation evoked by allergen inhalation. 16 Stress-induced brain activation results in the production and release of stress neuropeptides, such as opioid peptides, substance P, and histamine, which bind to membrane receptors in the central nervous system (CNS). 17, 18 However, the molecular mechanism linking psychological stress perceived in the CNS to exacerbations of asthma pathophysiology in airways is not yet fully understood. Histamine receptors (HRs) are a group of seven-transmembrane G protein-coupled receptors classified to four major subtypes (H 1 R, H 2 R, H 3 R, and H 4 R), which are expressed throughout the body including in immune cells, gastric mucosal cells, and neurons. 19 Histamine in the brain is produced by histaminergic neurons comprising the tuberomammillary nucleus in the posterior hypothalamus. Projections from the tuberomammillary nucleus extend to almost all areas in the brain and are implicated in basic homeostatic and higher brain functions such as arousal, cognition, nociception, and responses to perceived stress.
19e21
In the present study, we aimed to determine the role of HRs in the CNS in psychological stress-induced asthma exacerbations using a murine model of stress asthma. We found that H 1 Rs in the CNS were required for exacerbation of asthmatic airway responses induced by the stress exposure. In contrast, H 3/4 Rs might be irrelevant in this process or function in the negative feedback control of stressor signals in asthma exacerbation.
Methods

Mice and ethical statement
Specific pathogen-free female C57BL/6 mice were purchased from CLEA Japan (Osaka, Japan). All mice were kept under specific pathogen-free conditions at the Institute for Animal Experimentation, Tohoku Pharmaceutical University, Sendai, Japan. Mice were housed under a 12 h/12 h light/dark cycle at a constant temperature (22 ± 2 C). Sterilized food and water were available ad libitum. All experimental procedures involving animals were approved by the Committee of Animal Experiments at Tohoku Pharmaceutical University (approval numbers: 13001-cn-a, 14002-cn, and 15001-cn). We took the utmost care to alleviate any pain and suffering on the part of the mice.
Sensitization, antigen challenge, and stress exposure A schematic of the experimental protocol is shown in Figure 1 . Six-to eight-week-old mice were sensitized and made to inhale an aerosolized antigen as previously described. 22 26, 27 in calcium-and magnesium-free phosphatebuffered saline (PBS) was intracerebroventricularly administered to selectively block HRs in the CNS 1 h before each stress exposure at the dose indicated. Solvent was used as a negative control. Mice were placed in a stereotactic device under anesthesia induced by inhalation of 2% isoflurane in oxygen (DS Pharma Animal Health, Tokyo, Japan). A 25G microinjection needle tip was aligned with the bregma and then inserted into the ventricle using the following coordinates from bregma: 1.0 mm anterior and 1.0 mm lateral. Intracerebroventricular injection has been used generally to selectively administer agents to the CNS. 22 In our preliminary experiments, the intracerebroventricularly injected solution was not detected outside the CNS within 1 h for volumes below 5 mL. The doses of HR antagonists used herein were based on those used in previous studies. 28, 29 At the end of the experiments, the mice were euthanized by an overdose of pentobarbital (Somnopentyl; Kyoritsu Seiyaku, Tokyo, Japan).
Preparation of bronchoalveolar lavage (BAL) fluids
BAL samples were collected with 2 Â 0.25 mL chilled PBS through a cannula inserted in the trachea. Total cell numbers recovered from BAL fluid were counted with a hemocytometer. After centrifugation of the BAL fluids, supernatants were stored at À80 C for cytokine assay. For each sample, 2 Â 10 5 cells were centrifuged onto a glass slide using a Cytospin 4 (Thermo Scientific, Waltham, MA, USA) and stained with Diff-Quick solution (International Reagents, Kobe, Japan). The fractions of leukocytes were analyzed by counting a minimum of 200 cells under a light microscope.
Measurement of airway responsiveness
Lung resistance at the baseline and in response to aerosolized saline and acetyl-b-methylcholine (methacholine; SigmaeAldrich) were measured for 3 min under each condition. 22 To measure airway sensitivity, the concentration of acetyl-b-methylcholine needed to increase lung resistance to 200% above baseline (PC 200 ) was calculated by interpolating the log concentration-lung resistance curve from individual mice.
Lung histology
Lungs were isolated from mice 3 days after the last OVA challenge, fixed in 10% buffer formalin, dehydrated, and embedded in paraffin. Sections were cut at 4-mm-thick and stained with periodic acideSchiff (PAS). Mucin production was estimated as the proportion of PAS-positive cells in the total airway epithelium of bronchioles in the PAS-stained section. The percentage of PAS-positive cells was calculated in each of five random bronchioles in three lung sections from each mouse.
Measurement of OVA-specific IgE and cytokine
Serum samples were collected 3 days after the last OVA challenge. The quantities of OVA-specific IgE in serum were measured by enzyme-linked immunosorbent assay (ELISA). Briefly, microtiter plates (Nunc A/S, Roskilde, Denmark) were coated with 10 mg/mL OVA in bicarbonate buffer for 1 h at 37 C and then blocked with 1% bovine serum albumin (BSA) in PBS at 4 C overnight. Prior to testing, serum samples were diluted with 1% BSA/PBS. Horseradish peroxidase-conjugated goat anti-mouse IgE antibodies (Bethyl Laboratories, Montgomery, TX, USA) diluted 1:2500 were used for detection. IgE concentrations were determined from the absorbance at 450 nm using that at 650 nm for reference and calculated based on a reference standard of pooled sera from sensitized female mice assigned as 1000 experimental units (EU)/mL. The sensitivity was 1.9 Â 10 À2 EU/mL for IgE. The concentrations of IL-13 in BAL fluids were measured using an ELISA kit (eBioscience, San Diego, CA, USA) according to the manufacturer's instructions. The limit of detection was 1.5 pg/mL.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA). Differences between the two groups were tested using two-tailed analysis in an unpaired Student's t-test. Differences among four or more groups were tested using ANOVA with post hoc analysis (Tukey's multiple comparison test). A p-value less than 0.05 was considered significant. Data are expressed as the mean ± standard error of the mean (SEM).
Results
Effects of HR antagonists on stress-induced exacerbations of airway inflammation
The numbers of total cells, eosinophils, and lymphocytes in BAL fluid were significantly increased by the stress exposure but showed a dose-dependent reduction with epinastine treatment (Fig. 2) . Treatment with 3.0 Â 10 À9 mol epinastine significantly reduced the numbers of inflammatory cells in stressed mice to the levels observed in non-stressed mice treated with the same dose of epinastine and tended to reduce the numbers of total cells, eosinophils, and lymphocytes in BAL fluids of non-stressed mice compared with solvent treatment, although the difference was not statistically significant (Fig. 2) . Intracerebroventricular administration of 3.0 Â 10 À9 mol ranitidine significantly reduced the increased numbers of total cells, eosinophils, and lymphocytes in BAL fluids of stressed mice, whereas treatment with a higher dose (3.0 Â 10 À8 mol) of ranitidine did not reduce the stress-induced increases ( Supplementary Fig. 1 ). The effects of ranitidine in stressed mice were not dose-dependent but reverse bell-shaped. The maximal suppressive effect was observed at 3.0 Â 10 À9 mol.
In contrast, the effects of ranitidine in non-stressed mice seemed to be dose-dependent but were not statistically significant ( Supplementary Fig. 1 ). Treatment with thioperamide, an H 3/4 R antagonist, did not significantly reduce the stress-induced increased numbers of inflammatory cells in BAL fluid (Fig. 3 ), even at a higher dosage (4.9 Â 10 À8 mol; data not shown).
Effects of an H 1 R antagonist, epinastine, on stress-induced exacerbations of asthmatic airway responses
Lung resistance increased dose-dependently in response to inhaled methacholine in all groups of mice. The lung resistance to 200% above baseline (PC 200 ) with solvent treatment tended to be lower in stressed mice than in non-stressed mice, although the difference was not significant (Fig. 4) . In the stressed mice, epinastine treatment significantly increased the PC 200 to a level similar to that in the non-stressed mice treated with epinastine. However, in the non-stressed mice, no significant difference in PC 200 was observed between solvent and epinastine treatments.
Effects of epinastine on stress-induced exacerbations of airway mucus secretion
The number of PAS-positive cells under solvent treatment was significantly higher in the stressed mice than in the non-stressed mice (Fig. 5) . In the stressed mice, treatment with epinastine significantly reduced the number of PAS-positive cells to the level observed for non-stressed mice treated with epinastine. However, in the non-stressed mice, no significant difference in cell number observed between solvent and epinastine treatments.
Effects of epinastine on the stress-induced increase of IL-13 in BAL fluid
The IL-13 contents in BAL fluids under solvent treatment were significantly higher in the stressed mice than in the non-stressed mice (Fig. 6 ). In the stressed mice, treatment with epinastine significantly reduced the IL-13 contents to the levels measured for non-stressed mice treated with epinastine. In the non-stressed mice, there was no significant difference in IL-13 contents between solvent and epinastine treatments.
Effects of epinastine on the stress-induced increase of OVA-specific IgE in sera OVA-specific IgE concentrations in sera under solvent treatment tended to be higher in the stressed mice than in the non-stressed mice, although the difference was not statistically significant (Fig. 7) . In the stressed mice, treatment with epinastine significantly decreased IgE concentrations to the levels of those in the non-stressed mice treated with epinastine. In the non-stressed Data are shown as the mean ± SEM.*p < 0.05 compared with non-stressed mice treated with solvent using an unpaired Student's t-test. Differences among the data on the stressed mice or non-stressed mice were tested using ANOVA with Tukey's multiple comparison test. #p < 0.05 compared with the stressed mice treated with solvent. NS, not significantly different. exposure. The numbers of inflammatory cells in bronchoalveolar lavage fluid were counted on day 3 after the last OVA challenge. Each group consisted of three to four mice from two independent experiments. Data are shown as the mean ± SEM. *p < 0.05 compared with the non-stressed mice treated with solvent using an unpaired Student's t-test. Differences among the data on the stressed mice were tested using ANOVA with Tukey's multiple comparison test. NS, not significantly different.
mice, epinastine treatment yielded no significant difference in IgE concentrations compared with solvent treatment.
Discussion
To our knowledge, this is the first report demonstrating that HRs in the CNS are involved in both the development and psychological stress-induced exacerbations of allergic asthma. Histamine is a neurotransmitter whose release is upregulated in response to perceived stress. 19 Ito et al. showed that chronic RS increased histamine turnover in the nucleus accumbens and striatum in Fisher rats. 30 In addition, Gadek-Michalska et al. showed that intracerebroventricular administration of an H 1 R agonist in rats increased the levels of corticosterone, one of the stress hormones released in the neuroendocrine response to psychological stress. 31 The increase of serum corticosterone after stress exposure was previously observed in this model of stress asthma. 22 Therefore, it is likely that histamine was released upon stress exposure in the present study. Epinastine seemed to increase the PC 200 (Fig. 4) , and reduce the eosinophil counts (Fig. 2) , the IL-13 contents in BAL fluid (Fig. 6 ) and the OVA-specific IgE levels in sera (Fig. 7) of non-stressed mice compared with solvent treatment, although the differences were was administered intracerebroventricularly before each stress exposure. Airway sensitivity was measured 1 day after the last OVA challenge. Each group consisted of six to eight mice from two independent experiments. Data are shown as the mean ± SEM. #p < 0.05 compared with the stressed mice treated with solvent using an unpaired Student's t-test. not statistically significant. In addition, ranitidine tended to dosedependently reduce the eosinophil counts in non-stressed mice compared with solvent treatment. Previous studies demonstrated that H 1 Rs mediated the excitatory CNS functions of brain histamine such as maintenance of wakefulness, acceleration of locomotor activity, enhancement of learning and memory processes, and increased pain perception, and H 2 Rs are thought to play similar roles. 19, 32 Therefore, histamine physiologically released in the CNS might be partially involved in the development of allergic airway responses through the activation of H 1 Rs and H 2 Rs, which could explain the (non-significant) epinastine-and ranitidine-mediated decreases in the development of allergic asthma under stress-free conditions. However, we cannot rule out the possibility that the procedure for intracerebroventricular administration of solvent could induce stress via HR activation in the non-stressed mice. In our previous study investigating the effect of a glucocorticoid receptor antagonist using the same stress model, 22 subcutaneous administration of the solvent tended to aggravate allergic airway responses in non-stressed mice compared to untreated nonstressed mice (unpublished data). Thus, epinastine and ranitidine might attenuate the aggravation of asthma-related features caused by stress from handling in non-stressed mice. Epinastine (3.0 Â 10 À9 mol) and ranitidine (3.0 Â 10 À9 mol)
significantly attenuated the stress-induced enhancement of asthmatic airway responses and Th2 immune responses to the levels of non-stressed mice treated with the antagonists ( Supplementary  Fig. 1, Fig. 2,4 ,5,6,7). These results suggest that the stress exposure exaggerated asthmatic airway responses by increasing histamine release, leading to the further activation of H 1 Rs and H 2 Rs in the CNS. On the other hand, the intracerebroventricular administration of an H 3/4 R antagonist, thioperamide, exhibited no significant effect on the airway inflammation at the same dose (Fig. 3) or at a higher dose (4.9 Â 10 À8 mol; data not shown). However, within the group receiving thioperamide administration, a bell-shaped enhancement effect was observed, and the maximal effect was observed at 0.3 Â 10 À9 mol. H 3 Rs act as inhibitory auto-and hetero-receptors in the CNS, which inhibit the synthesis and release of histamine 19, 33 and a number of neurotransmitters, including acetylcholine, dopamine, noradrenaline, and serotonin, in a pathway-dependent manner, leading to suppression of convulsion, stress-induced excitation, and feeding behavior. 20, 21 The structureeactivity relationships of H 3 R and H 4 R overlap as G i/o protein-coupled receptors. 34 Therefore, the activation H 3 Rs and H 4 Rs by the stress exposure might play a suppressive role in stress-induced asthma exacerbations. Taken together, our findings and the physiological properties of each HR subtype suggest that the interaction of histamine with HR subtypes playing distinctive roles in the CNS is associated with the severity of allergic airway responses, particularly in the case of psychological stress-induced exacerbations. Further studies will be required to identify the exact roles of each HR subtype in the CNS and to elucidate how the stressor signal via HRs in the CNS modulates Th2 immune responses in asthmatic pathophysiology. The present study presents a new insight into the global role of the histamine-regulated CNS in allergic asthma, which might lead to the development of more effective strategies for the management of asthmatic patients with the stress-related asthma phenotype.
